On December 12, 2022, Larkspur Health Acquisition Corp. closed the transaction. The company issued 8,635 series A convertible preferred stock at a purchase price of $1,000 per share for gross proceeds of $8,635,000.

Each Share is convertible into a number of shares of the Company's common stock equal to the purchase price divided by the conversion price. The initial conversion price is $10.00, subject to adjustments as described herein. The warrants are exercisable for shares of the Company's common stock at an exercise price of $11.50 per share.

The share are converted into 863,500 common stock.